5G adoption
Search documents
Is Teradyne Stock Underperforming the S&P 500?
Yahoo Financeยท 2025-09-17 11:26
Company Overview - Teradyne, Inc. (TER) has a market cap of $18.1 billion and is a leading supplier of automated test equipment (ATE) and industrial automation solutions, headquartered in North Reading, Massachusetts. The company was founded in 1960 and provides products and services that ensure the quality and reliability of semiconductors, electronics, and industrial systems [1]. Market Position and Growth Drivers - Teradyne is classified as a "large-cap" stock due to its valuation exceeding $10 billion. The company has a diversified portfolio across semiconductor test, system test, wireless test, and industrial automation, which provides multiple growth drivers and reduces reliance on any single market. It is well-positioned to benefit from trends such as the expansion of AI-driven chips, 5G adoption, and increasing demand for robotics and factory automation through its Universal Robots and MiR businesses [2]. Stock Performance - Teradyne shares reached a 52-week high of $144.16 on January 7 but have since declined by 21%. Over the past three months, shares surged by 29.9%, outperforming the S&P 500 Index, which returned 9.5% during the same period [3][4]. - Year-to-date, Teradyne has fallen by 9.5%, lagging behind the S&P 500's 12.3% rise. Additionally, shares have dipped nearly 11% over the past 52 weeks, compared to the S&P 500's 17.3% rally [4]. Recent Developments - On August 25, Teradyne shares increased by 1.5% following the announcement of a quarterly cash dividend of $0.12 per share, payable on September 29, 2025. In contrast, its main competitor, ACM Research, Inc. (ACMR), has significantly outperformed Teradyne, with ACMR shares soaring 104.9% year-to-date and 89% over the last 52 weeks [5]. Analyst Outlook - Despite Teradyne's underperformance over the past year, analysts maintain a moderately optimistic outlook. The consensus rating for Teradyne is "Moderate Buy" from 18 analysts, with a mean price target of $117.38, indicating a potential upside of 3% from current price levels [6].